These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 4867679

  • 1. [Pathogenesis of polycystic ovaries. Comparison with the endocrine activity of the testicles].
    Jayle MF.
    Rev Fr Endocrinol Clin; 1967; 8(5):373-89. PubMed ID: 4867679
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of the estrogen feedback control mechanism between women with normal and polycystic ovaries.
    Lopez JM, Migeon CJ, Jones GS.
    Am J Obstet Gynecol; 1969 Feb 15; 103(4):555-65. PubMed ID: 5764182
    [No Abstract] [Full Text] [Related]

  • 3. [Site of synthesis and metabolism of androgens and the hypothalamo-hypophyseal system function in the polycystic ovary syndrome-therapeutic implications].
    Milewicz A.
    Pol Tyg Lek; 1981 Jun 08; 36(23):849-51. PubMed ID: 7279774
    [No Abstract] [Full Text] [Related]

  • 4. [Endocrinological environment in polycystic ovarian disease (PCOD)].
    Fujimoto S, Tanaka T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Sep 08; 40(9):1465-70. PubMed ID: 3049852
    [No Abstract] [Full Text] [Related]

  • 5. [Adrenal cortex and ovarian intervention in the pathogenesis of minor hyperandrogenism. I. Study of fractionated urinary 17-ketosteroids in basal and dynamic conditions in 30 women with hirsutism].
    Minozzi M, Faggiano M, Salerno M, Orio F, Lombardi G, Jori JP.
    Folia Endocrinol; 1967 Dec 08; 20(6):736-64. PubMed ID: 4303786
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [In vivo studies on metabolism of androgens following administration of steroid inhibitors of ovulation. 1. Changes in the secretion of androgens and excretion of their metabolites in normal subjects and women with the Stein-Leventhal syndrome].
    Mauvais-Jarvis P, Jayle MF, Decourt J, Louchart J, Truffert J.
    Acta Endocrinol (Copenh); 1965 Sep 08; 50(1):131-44. PubMed ID: 5897059
    [No Abstract] [Full Text] [Related]

  • 8. Combined dexamethasone and human chorionic gonadotropin in diagnosis of polycystic ovarian disease.
    Beck WW, McEvoy D, Wallach EE.
    Obstet Gynecol; 1971 Feb 08; 37(2):211-7. PubMed ID: 5539356
    [No Abstract] [Full Text] [Related]

  • 9. [Endogenous stimulation of the ovary in patients with Stein-Leventhal syndrome].
    Halbe HW, De Paula E Silva P.
    Rev Hosp Clin Fac Med Sao Paulo; 1968 Apr 08; 23(2):73-7. PubMed ID: 5658805
    [No Abstract] [Full Text] [Related]

  • 10. Urinary oestrogen excretion after metyrapone administration to patients with the polycystic ovary syndrome.
    Sfikakis AP, Ikkos DG, Diamandopoulos KN.
    J Endocrinol; 1967 Sep 08; 39(1):61-9. PubMed ID: 6050964
    [No Abstract] [Full Text] [Related]

  • 11. [Origin of hyperandrogenism in Stein-Leventhal syndrome].
    Markovski S.
    Akush Ginekol (Sofiia); 1976 Sep 08; 15(2):137-41. PubMed ID: 952385
    [No Abstract] [Full Text] [Related]

  • 12. [Current patholophysiologic and morphologic concepts of polycystic disease of the ovary].
    Vulkov I, Georgiev Ch.
    Akush Ginekol (Sofiia); 1982 Sep 08; 21(3):238-43. PubMed ID: 6289691
    [No Abstract] [Full Text] [Related]

  • 13. [Ovarian functional disorders].
    Bazot M, Robert Y, Mestdagh P, Boudghène F, Rocourt N.
    J Radiol; 2000 Dec 08; 81(12 Suppl):1801-18. PubMed ID: 11173749
    [Abstract] [Full Text] [Related]

  • 14. [Polycystic ovarian disease. 1. The current data on its etiology and pathogenesis].
    Rachev E.
    Akush Ginekol (Sofiia); 1999 Dec 08; 38(2):42-5. PubMed ID: 10730388
    [No Abstract] [Full Text] [Related]

  • 15. [POLYCYSTIC OVARIES. ENDOCRINE ASPECTS].
    REFORZOMEMBRIVES J.
    Prensa Med Argent; 1963 May 31; 50():1353-4. PubMed ID: 14081178
    [No Abstract] [Full Text] [Related]

  • 16. Hypothesis: aberrant puberty and the Stein-Leventhal syndrome.
    Mechanick JI, Futterweit W.
    Int J Fertil; 1984 May 31; 29(1):35-8. PubMed ID: 6146582
    [Abstract] [Full Text] [Related]

  • 17. [Combination of ACTH dexamethazone and HCG in the differential diagnosis of hirsutism and polycystic ovaries (author's transl)].
    Divila F, Presl J, Stroufová A, Kozlová J, Horský J.
    Cesk Gynekol; 1973 Sep 31; 38(8):627-9. PubMed ID: 4358102
    [No Abstract] [Full Text] [Related]

  • 18. [Physiological problems of puberty. II. Peripheral endocrine secretions].
    Sizonenko PC, Lewin M, Burr IM.
    Arch Fr Pediatr; 1972 Feb 31; 29(2):185-201. PubMed ID: 4262472
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of ovarian and adrenal sources of androgens in women with polycystic ovary syndrome. Dexamethasone and GnRH-agonist administration.
    Fulghesu AM, Lanzone A, Fortini A, Guido M, Caruso A, Mancuso S.
    J Reprod Med; 1993 May 31; 38(5):387-92. PubMed ID: 8320677
    [Abstract] [Full Text] [Related]

  • 20. [Longitudinal study of urinary excretion of testosterone glucuronate, neuter 17-ketosteroids and 17-ketogenic corticoids in normal subjects].
    Bianchi G, Indiveri F, Rolandi E.
    Arch Maragliano Patol Clin; 1970 May 31; 26(1):13-20. PubMed ID: 5467883
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.